Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

923166

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government by what mechanism units of dental activity are distributed to dental practitioners.
	tabling member printed	Lord Storey
	uin	HL8630
	answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>Dental contracts and agreements are agreed with dental contract holders by NHS England. Contracts are held by the part of NHS England (the area team) responsible for that region. Each contract has a set value and agreed level of dental activity to be delivered for that value per year. Activity is measured in metrics known as units of dental activity.</p><p> </p><p>Contracts are let by tender under public procurement regulations. The current system was established in 2006. Where a contract existed prior to 2006, it was transferred into the new system and values set under a national formula used to transfer all then existing contracts from the pre-2006 system to the current system.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:13:38 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	4238 label Biography information for Lord Storey

923140

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Human Papillomavirus: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is the efficacy of the human papilloma virus (HPV) vaccination programme in women and girls who may already have had exposure to HPV infection, either naturally or as the result of sexual abuse, prior to receiving that vaccine.
	tabling member printed	The Countess of Mar
	uin	HL8604
	answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>The human papillomavirus (HPV) vaccines have demonstrated very high vaccine efficacy against the vaccine types and related disease in clinical trials when administered to HPV-naïve women (i.e. women with no current or previous vaccine-type HPV infection). However, results from these trials also demonstrated that HPV vaccination of women with a current vaccine-type HPV infection had little or no effect on clearance of the existing infection. There is also some evidence of a slightly reduced vaccine efficacy against pre-cancerous abnormalities among young women currently not infected with HPV but with serological evidence of a previous exposure.</p><p> </p><p>Public Health England has conducted surveillance to monitor the prevalence of type-specific genital HPV infections in 16-24 year old sexually active women in England who would have been eligible to receive the HPV vaccine. The latest data, including specimens collected to the end of 2016, demonstrated a vaccine effectiveness of 82.0% against infections with HPV16/18 among women vaccinated at age 15 years or younger. The vaccine effectiveness in women who would have been vaccinated at age 16 to 18 years old was 48.7%. This suggests that the vaccine works best when given to young girls before they are exposed to HPV. However it also shows that older girls still benefit from vaccination.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 16:37:27 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1861 label Biography information for The Countess of Mar

923139

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Human Papillomavirus: Vaccination
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is the rate of ectropions in the cohorts who received human papilloma virus vaccinations.
	tabling member printed	The Countess of Mar
	uin	HL8603
	answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>Data are not collected on the rate of ectropions in the cohorts who received human papillomavirus vaccinations.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:12:23 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1861 label Biography information for The Countess of Mar

923138

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Human Papillomavirus
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether colposcopy clinics test all human papilloma virus (HPV) infections for strain types in cohorts of women who were offered HPV vaccination; and if not, why not.
	tabling member printed	The Countess of Mar
	uin	HL8602
	answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>Human papillomavirus (HPV) triage testing is performed in the screening programme on specimens collected from women attending for cervical screening which show borderline or low grade abnormalities. If this test identifies a high-risk HPV infection then the woman will be referred to colposcopy. No further HPV testing is conducted in colposcopy on these specimens to identity the specific HPV types. It is not the role of colposcopy to test HPV infections.</p><p>However, Public Health England does carry out surveillance which has demonstrated a reduction in the HPV types included in the vaccines since the introduction of the national vaccination programme.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:12:15 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1861 label Biography information for The Countess of Mar

923137

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Human Papillomavirus
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether the strain of human papilloma virus (HPV) is tested for when an HPV infection is found in women who were offered HPV vaccination; and if so, what were the rates of the different strains found in women who were (1) 13–18 years old, and (2) older than 18.
	tabling member printed	The Countess of Mar
	uin	HL8601
	answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>Human papillomavirus (HPV) testing is performed on specimens collected from some women attending for cervical screening as part of the NHS Cervical Screening Programme (women with borderline or low grade abnormalities, and women in areas piloting HPV primary testing). This test identifies if a high-risk HPV infection is present, but does not identify all the specific HPV types which are present.</p><p>Public Health England has also been monitoring the prevalence of type-specific genital HPV infections through surveys that use specimens from 16-24-year-old sexually active women in England who would have been eligible to receive the HPV vaccine. The latest data, including specimens collected to the end of 2016, has shown a clear reduction in the two high-risk HPV types included in the vaccine and in some other closely related HPV types not included in the vaccine among women aged 16-18 years old. Declines were also seen in women aged 19-21 years old. The prevalence of other high-risk HPV types has not changed.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:14:31 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	1861 label Biography information for The Countess of Mar

923154

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Expenditure
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they can provide a breakdown of health service spending by gender since 2008.
	tabling member printed	Lord Pearson of Rannoch
	uin	HL8618
	answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>The information is not available in the format requested.</p><p>The majority of National Health Service funding is allocated to NHS England, primarily for the commissioning of healthcare services from a range of primary and secondary care providers. NHS England allocates funding to clinical commissioning groups (CCGs). The model for CCG allocations is made up of three separate formulas – CCG core allocations, primary care and specialised services. Each formula is made up of a number of segments (for example, services covered by CCG core allocations include the segments maternity, mental health, prescribing, general and acute and supply needs). Each segment may be affected by the local population’s attributes, for example sex, age, morbidity, rates of disability, excess deaths and deprivation, plus wider factors associated with health needs including housing status and unemployment.</p><p>The statistical allocations formula is built up from data, which the NHS holds on individuals and their use of hospital services. This person-based approach helps ensure accuracy and takes account of local variation in health needs. Data for patients in general practitioner (GP) practices are linked to their treatment records, to calculate overall cost of care. The costs of health services for millions of real patients over a number of years are reviewed. Statistical analysis identifies factors, which can be used to predict future spending, for a given sex-age group in any GP practice in England (all data used is non-identifiable). Allocations reflect and build on information about spending patterns, but they do not report past spending patterns and therefore it is not possible to calculate costs per patient and so therefore not possible to calculate costs by gender over a given time period.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:13:11 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	3153 label Biography information for Lord Pearson of Rannoch